Li Bing, Zhang Zhiqiang, Li Junping, Liu Xiaoqiang
Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Graduate School of Tianjin Medical University, Tianjin Medical University, Tianjin, 300070, China.
BMC Urol. 2025 Jul 3;25(1):153. doi: 10.1186/s12894-025-01844-1.
OBJECTIVE: Currently, evidence regarding the relationship between variations in the Triglyceride Glucose-Waist-to-Height Ratio (TyG-WHtR) and benign prostatic hyperplasia (BPH) remains scarce. This study aimed to examine the potential association between alterations in TyG-WHtR and the risk of developing BPH. METHODS: This study enrolled 3,296 male participants aged ≥ 45 years from the China Health and Retirement Longitudinal Study (CHARLS). Multivariable logistic regression analysis combined with restricted cubic spline models was employed to explore the potential relationship between TyG-WHtR variation and the risk of developing BPH. RESULTS: Over a 4-year follow-up period, 267 individuals were diagnosed with BPH. Elevated TyG-WHtR values were significantly associated with a higher risk of BPH (OR = 1.20, 95% CI: 1.02-1.43, p = 0.031), demonstrating a clear dose-response trend (p = 0.01). Furthermore, subgroup analyses revealed that this positive correlation between TyG-WHtR and BPH risk was consistently observed across multiple stratifications. CONCLUSION: These findings highlight the potential metabolic links between TyG-WHtR and BPH, and underscore the need for future longitudinal studies to explore whether targeting these pathways may aid in BPH prevention.
目的:目前,关于甘油三酯葡萄糖-腰高比(TyG-WHtR)变化与良性前列腺增生(BPH)之间关系的证据仍然稀少。本研究旨在探讨TyG-WHtR改变与发生BPH风险之间的潜在关联。 方法:本研究纳入了来自中国健康与养老追踪调查(CHARLS)的3296名年龄≥45岁的男性参与者。采用多变量逻辑回归分析并结合限制性立方样条模型,以探讨TyG-WHtR变化与发生BPH风险之间的潜在关系。 结果:在4年的随访期内,267人被诊断为BPH。TyG-WHtR值升高与BPH风险较高显著相关(OR = 1.20,95%CI:1.02 - 1.43,p = 0.031),呈现出明显的剂量反应趋势(p = 0.01)。此外,亚组分析显示,在多个分层中均一致观察到TyG-WHtR与BPH风险之间的这种正相关。 结论:这些发现突出了TyG-WHtR与BPH之间潜在的代谢联系,并强调未来有必要进行纵向研究,以探索针对这些途径是否有助于预防BPH。
Beijing Da Xue Xue Bao Yi Xue Ban. 2025-6-18
J Health Popul Nutr. 2025-5-9
Med Clin (Barc). 2024-10-25